Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Products and methods for monitoring adherence to nucleoside reverse transcriptase inhibitor therapy

US Patent 11795239 · Granted Oct 24, 2023

Estimated economic value: $5,443,000

Assignee

Inventors

View full patent text on Google Patents →